Item 8.01. Other Events.

On July 30, 2021, Cerevel Therapeutics Holdings, Inc. (the "Company") issued a press release announcing the redemption of all of its outstanding public warrants to purchase shares of the Company's common stock that were issued under the Warrant Agreement, dated as of June 9, 2020 (the "Warrant Agreement"), by and between the Company (f/k/a ARYA Sciences Acquisition Corp II) and Continental Stock Transfer & Trust Company, as warrant agent. A copy of the press release is filed as Exhibit 99.1 hereto and is incorporated herein by reference.

A copy of the Notice of Redemption delivered by the Company is filed as Exhibit 99.2 hereto and is incorporated herein by reference. None of this Current Report on Form 8-K, the press release attached hereto as Exhibit 99.1 nor the Notice of Redemption attached hereto as Exhibit 99.2 constitutes an offer to sell or the solicitation of an offer to buy any Company securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offering, solicitation or sale would be unlawful.

Item 9.01. Financial Statements and Exhibits.




(d)  Exhibits



                 99.1     Press Release issued by the Company on July 30, 2021.

                 99.2     Notice of Redemption, dated July 30, 2021.




                                       1

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses